Mifamurtide for the treatment of osteosarcoma
1.1 Mifamurtide in combination with postoperative multi-agent chemotherapy is recommended
within its licensed indication as an option for the treatment of high-grade resectable nonmetastatic
osteosarcoma after macroscopically complete surgical resection in children,
adolescents and young adults and when mifamurtide is made available at a reduced cost to the
NHS under the patient access scheme.
NICE technology appraisal guidance 235 Issued: October 2011